Human immunodeficiency virus type 1 Nef, Tat, and Vif proteins (HIV-1 Nef/Tat/Vif)

HIV-1 Nef, Tat, and Vif are essential non-structural proteins that coordinate the viral life cycle and host immune subversion. Tat is a potent transactivator of the viral LTR promoter, required for efficient transcription of the HIV genome by binding to the TAR RNA element [3, 6]. Nef acts as a major virulence factor by downregulating host cell surface receptors, such as CD4 and MHC-I, which promotes viral spread and allows infected cells to evade cytotoxic T lymphocyte recognition [1, 9]. Vif is critical for viral infectivity as it neutralizes the host's innate antiviral defense by targeting the APOBEC3G protein for proteasomal degradation [4, 6]. These proteins are frequently targeted in multi-antigen therapeutic vaccines, such as the HIV-MAG DNA vaccine, to elicit broad cellular immune responses and potentially clear the latent viral reservoir [27, 34]. Experimental small molecules, including Nef-specific hydroxypyrazoles and Tat-inhibiting cortistatin analogs, are also under investigation to disrupt these viral functions [10, 37].

Other names

HIV-1 accessory and regulatory proteinsNef-Tat-Vif fusion proteinHIV-1 Nef/Tat/Vif antigensNefTatVif

Tat binds to the TAR RNA element to transactivate the viral LTR promoter, driving high-level transcription; Nef downregulates CD4 and MHC-I from the cell surface via endosomal trafficking to facilitate viral release and immune escape; Vif recruits the Cullin-5 E3 ubiquitin ligase complex to degrade host APOBEC3G, preventing viral genome mutagenesis.